SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-249423
Filing Date
2023-10-03
Accepted
2023-10-03 06:04:00
Documents
15
Period of Report
2023-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d559817d8k.htm   iXBRL 8-K 53089
2 EX-3.1 d559817dex31.htm EX-3.1 20787
3 EX-4.1 d559817dex41.htm EX-4.1 255605
4 EX-99.1 d559817dex991.htm EX-99.1 15766
  Complete submission text file 0001193125-23-249423.txt   551624

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA meip-20231001.xsd EX-101.SCH 2857
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20231001_lab.xml EX-101.LAB 18740
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20231001_pre.xml EX-101.PRE 11712
9 EXTRACTED XBRL INSTANCE DOCUMENT d559817d8k_htm.xml XML 3549
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231301506
SIC: 2834 Pharmaceutical Preparations